Immunome Inc. Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment #1 to Master License Agreement, by and between Morphimmune, Inc. and Purdue Research Foundation, dated October 16, 2024
License Agreements
Immunome Inc.
Biotechnology
2025
Amendment No. 2 to License Agreement, dated August 7, 2024, by and between Immunome, Inc. and Bristol-Myers Squibb Company
License Agreements
Immunome Inc.
Biotechnology
DE
2024
License Agreement, by and between the registrant and Zentalis Pharmaceuticals, Inc., dated January 5, 2024
License Agreements
Immunome Inc.
Biotechnology
PA
2024
License Agreement dated November 29, 2017, by and between Immunome, Inc. (as assignee) and Bristol-Myers Squibb Company, as amended
License Agreements
Immunome Inc.
Biotechnology
DE
2024
Master License Agreement, by and between Morphimmune, Inc. and Purdue Research Foundation, dated as of January 19, 2021, as modified pursuant to that certain email by Max Rosett...
License Agreements
Immunome Inc.
Biotechnology
IN
2023
Amendment #2 to the License Agreement by and between the registrant and Arrayjet Limited, dated December 30, 2022
License Agreements
Immunome Inc.
Biotechnology
2023
Second Amendment to License Agreement by and between the registrant and Thomas Jefferson University, dated July 28, 2020
License Agreements
Immunome Inc.
Biotechnology
2020